{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:26:39Z","timestamp":1764044799901,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Ondansetron is widely used for prophylaxis of postoperative nausea and vomiting (PONV) after general anesthesia. While previous studies have emphasized its early use, the effects of ondansetron in intensive care unit (ICU) patients following cardiac surgery remain unclear. This study investigates the association between postoperative ondansetron exposure and the risk of mortality, acute kidney injury (AKI), and postoperative atrial fibrillation (POAF) in ICU patients after cardiac surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study utilizing data from the MIMIC-IV database. Adult patients who underwent cardiac surgery and were subsequently admitted to the ICU were included. Cox proportional hazards models were employed to assess the effect of ondansetron exposure on ICU and 28-day mortality. Multivariable logistic regression analyses examined the associations between ondansetron exposure and the incidence of AKI (2-day and 7-day) and POAF. Sensitivity analyses included Propensity Score Matching (PSM) and the inclusion of patients with ICU stays of less than 24\u00a0h to ensure robustness of results. Subgroup analyses explored the effects of age and other clinical factors, with interaction tests to examine differential impacts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 7,170 were included. The incidence of AKI was 74.4% at 2\u00a0days and 76.7% at 7\u00a0days post-surgery. The 28-day postoperative mortality rate was 1.4%, while the ICU mortality rate was 1.0%. POAF occurred in 17.4% of the patients. Ondansetron exposure was not associated with 28-day mortality or ICU mortality (<jats:italic>p<\/jats:italic> &amp;gt; 0.05). However, after PSM, ondansetron exposure was significantly associated with an elevated risk of AKI at 2\u00a0days (OR 1.28, 95% CI 1.13\u20131.45, <jats:italic>p<\/jats:italic> &amp;lt; 0.001] and 7\u00a0days (OR 1.25, 95% CI 1.15\u20131.45, <jats:italic>p<\/jats:italic> &amp;lt; 0.001), as well as POAF (OR 1.20, 95% CI 1.04\u20131.39, <jats:italic>p<\/jats:italic> = 0.014).Subgroup analysis revealed a stronger association in patients aged over 65 years, where ondansetron was linked to an increased risk of 7-day AKI (OR 1.51, 95% CI 1.29\u20131.78, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and POAF (OR 1.31, 95% CI 1.12\u20131.53, <jats:italic>p<\/jats:italic> = 0.001). Interaction tests showed a significant interaction between ondansetron exposure and age (P for interaction = 0.018 for AKI and P for interaction = 0.02 for POAF). Sensitivity analyses, including patients with ICU stays of less than 24\u00a0h, confirmed the robustness of these findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In ICU patients following cardiac surgery, postoperative use of ondansetron is associated with an increased risk of both 7-day AKI and POAF, particularly in patients aged 65 years and older. These findings suggest that the use of ondansetron in this population should be approached with caution, especially in elderly patients who may be more susceptible to these complications. Further research is needed to explore the mechanisms underlying the association between ondansetron and these adverse outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1511545","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T12:16:49Z","timestamp":1734351409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Ondansetron use is associated with increased risk of acute kidney injury in ICU patients following cardiac surgery: a retrospective cohort study"],"prefix":"10.3389","volume":"15","author":[{"given":"Feiyi","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/s0753-3322(97)89285-2","article-title":"Effect of the 5-HT3 receptor antagonist ondansetron on plasma AVP secretion: a study in cancer patients","volume":"50","author":"Barreca","year":"1996","journal-title":"Biomed. Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1213\/ANE.0000000000006286","article-title":"The society of thoracic surgeons\/society of cardiovascular anesthesiologists\/American society for extracorporeal Technology clinical practice guidelines for the prevention of adult cardiac surgery-associated acute kidney injury","volume":"136","author":"Brown","year":"2023","journal-title":"Anesth. Analg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/ALN.0000000000004734","article-title":"Acute kidney injury after cardiac surgery: prediction, prevention, and management","volume":"139","author":"Cheruku","year":"2023","journal-title":"Anesthesiology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41569-019-0166-5","article-title":"Postoperative atrial fibrillation: mechanisms, manifestations and management","author":"Dobrev","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"101151","DOI":"10.1016\/j.arr.2020.101151","article-title":"The ageing kidney: molecular mechanisms and clinical implications","volume":"63","author":"Fang","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-022-03401-y","article-title":"Association between early ondansetron administration and in-hospital mortality in critically ill patients: analysis of the MIMIC-IV database","volume":"20","author":"Fang","year":"2022","journal-title":"J. Transl. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1213\/ane.0000000000004833","article-title":"Fourth consensus guidelines for the management of postoperative nausea and vomiting","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth. Analg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.287.10.1233","article-title":"Postoperative nausea and vomiting\u2014can it be eliminated?","volume":"287","author":"Gan","year":"2002","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1345\/aph.1L544","article-title":"Coronary vasospasm and atrial fibrillation associated with ondansetron therapy","volume":"43","author":"Havrilla","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MCC.0b013e3280102af7","article-title":"Acute kidney injury: epidemiology and diagnostic criteria","volume":"12","author":"Hoste","year":"2006","journal-title":"Curr. Opin. Crit. Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci. DATA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF03017789","article-title":"Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report","volume":"50","author":"Kasinath","year":"2003","journal-title":"Can. J. Anaesth."},{"key":"B13","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron. Clin. Pract."},{"key":"B14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jpeds.2016.08.058","article-title":"Risk of ventricular arrhythmias and association with ondansetron","volume":"179","author":"Moeller","year":"2016","journal-title":"J. Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/pds.4960","article-title":"Identifying drug combinations associated with acute kidney injury using association rules method","volume":"29","author":"Nishtala","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B17","doi-asserted-by":"publisher","first-page":"104419","DOI":"10.1016\/j.psyneuen.2019.104419","article-title":"Plasma oxytocin and vasopressin levels in young and older men and women: functional relationships with attachment and cognition","volume":"110","author":"Plasencia","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.21037\/atm-22-6256","article-title":"Association between ondansetron use and mortality of patients on mechanical ventilation in the intensive care unit: a retrospective cohort study","volume":"11","author":"Tao","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1097\/PCC.0000000000000776","article-title":"Effect of ondansetron on QT interval in patients cared for in the PICU","volume":"17","author":"Trivedi","year":"2016","journal-title":"Pediatr. Crit. Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrneph.2017.119","article-title":"Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment","volume":"13","author":"Wang","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.jacep.2024.05.030","article-title":"Predictors of late atrial fibrillation recurrence after cardiac surgery","volume":"10","author":"William","year":"2024","journal-title":"JACC Clin. Electrophysiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"885137","DOI":"10.3389\/fsurg.2022.885137","article-title":"Early postoperative ondansetron exposure is associated with reduced 90-day mortality in patients undergoing cardiac surgery","volume":"9","author":"Xiong","year":"2022","journal-title":"Front. Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/pace.13292","article-title":"Prolonged corrected QT interval in predicting atrial fibrillation: a systematic review and meta-analysis","volume":"41","author":"Zhang","year":"2018","journal-title":"Pacing Clin. Electrophysiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1511545\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T12:16:51Z","timestamp":1734351411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1511545\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":24,"alternative-id":["10.3389\/fphar.2024.1511545"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1511545","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"article-number":"1511545"}}